Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level
GLP one receptor agonists have been shown in other research to reduce inflammatory signaling and modulate immune pathways
The pharmacology is the same
2a), and was associated with an increase in lipid peroxidation products that could be suppressed by fer-1 (Fig
It is also interesting to me that the use of anticholinergics with GLP-1 agonists doesnt flag as a potential drug even though both can worsen/exacerbate gastroparesis